Some Stop Immunotherapy, Still Have Controlled Cancer – Medscape
Medscape |
Some Stop Immunotherapy, Still Have Controlled Cancer
Medscape Among 19 patients with advanced kidney cancer who had a treatment response with PD-1 or PD-L1 immunotherapy but then stopped the treatment early because of adverse events, nearly half (42%, n = 8) had a durable response, which means these patients … Impact of Early Immunotherapy Discontinuation in mRCC Antibiotics May Compromise Immunotherapy Efficacy in Kidney Cancer In advanced kidney cancer, antibiotic use lowers efficacy of immunotherapy, study finds |
